Top

Published in:

01-12-2015 | Diabetes Epidemiology (NM Maruthur, Section Editor)

Novel Risk Factors for Type 2 Diabetes in African-Americans

Authors: Ranee Chatterjee, Nisa M. Maruthur, David Edelman

Published in: Current Diabetes Reports | Issue 12/2015

Abstract

In the USA, compared to whites, African-Americans are disproportionately impacted by the diabetes epidemic. Traditional diabetes risk factors, such as obesity, are more common among African-Americans, but these traditional risk factors do not explain all of the disparity in diabetes risk. Recent research has identified novel environmental, lifestyle, physiologic, and genetic risk factors for diabetes, some of which appear to impact African-Americans more than whites. This manuscript reviews the recent literature to highlight some of these novel risk factors that may be contributing to the racial disparity in diabetes risk. Further study is needed of the modifiable risk factors for development of interventions to reduce the risk of diabetes in African-Americans, as well as other high-risk populations.

Brancati FL, Kao WH, Folsom AR, Watson RL, Szklo M. Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities study. JAMA. 2000;283(17):2253–9.CrossRefPubMed

2.•

Chatterjee R, Brancati FL, Shafi T, Edelman D, Pankow JS, Mosley TH, et al. Non-traditional risk factors are important contributors to the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities study. J Gen Intern Med. 2013. This is a large, population-based prospective cohort study that quantifies the impact of traditional and non-traditional risk factors on the racial disparity of diabetes risk in this cohort.

Agardh E, Allebeck P, Hallqvist J, Moradi T, Sidorchuk A. Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis. Int J Epidemiol. 2011;40(3):804–18.CrossRefPubMed

Espelt A, Arriola L, Borrell C, Larranaga I, Sandin M, Escolar-Pujolar A. Socioeconomic position and type 2 diabetes mellitus in Europe 1999–2009: a panorama of inequalities. Curr Diabetes Rev. 2011;7(3):148–58.CrossRefPubMed

Spanakis EK, Golden SH. Race/ethnic difference in diabetes and diabetic complications. Curr Diab Rep. 2013;13(6):814–23.CrossRefPubMed

Gaskin DJ, Thorpe Jr RJ, McGinty EE, Bower K, Rohde C, Young JH, et al. Disparities in diabetes: the nexus of race, poverty, and place. Am J Public Health. 2014;104(11):2147–55.PubMedCentralCrossRefPubMed

Insaf TZ, Strogatz DS, Yucel RM, Chasan-Taber L, Shaw BA. Associations between race, lifecourse socioeconomic position and prevalence of diabetes among US women and men: results from a population-based panel study. J Epidemiol Community Health. 2014;68(4):318–25.CrossRefPubMed

Hasson RE, Adam TC, Pearson J, Davis JN, Spruijt-Metz D, Goran MI. Sociocultural and socioeconomic influences on type 2 diabetes risk in overweight/obese African-American and Latino-American children and adolescents. J Obes. 2013;2013:512914.PubMedCentralCrossRefPubMed

Unger JB, Reynolds K, Shakib S, Spruijt-Metz D, Sun P, Johnson CA. Acculturation, physical activity, and fast-food consumption among Asian-American and Hispanic adolescents. J Community Health. 2004;29(6):467–81.CrossRefPubMed

10.

Moulton CD, Pickup JC, Ismail K. The link between depression and diabetes: the search for shared mechanisms. Lancet Diabetes Endocrinol. 2015;3(6):461–71.CrossRefPubMed

11.

Holt RI, de Groot M, Golden SH. Diabetes and depression. Curr Diab Rep. 2014;14(6):491.PubMedCentralCrossRefPubMed

12.

Everson-Rose SA, Meyer PM, Powell LH, Pandey D, Torrens JI, Kravitz HM, et al. Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care. 2004;27(12):2856–62.CrossRefPubMed

13.

Myers JK, Weissman MM. Use of a self-report symptom scale to detect depression in a community sample. Am J Psychiatry. 1980;137(9):1081–4.CrossRefPubMed

14.

Bray GA, Vollmer WM, Sacks FM, Obarzanek E, Svetkey LP, Appel LJ, et al. A further subgroup analysis of the effects of the DASH diet and three dietary sodium levels on blood pressure: results of the DASH-Sodium Trial. Am J Cardiol. 2004;94(2):222–7.CrossRefPubMed

15.

Casagrande SS, Wang Y, Anderson C, Gary TL. Have Americans increased their fruit and vegetable intake? The trends between 1988 and 2002. Am J Prev Med. 2007;32(4):257–63.CrossRefPubMed

16.

Villegas R, Liu S, Gao YT, Yang G, Li H, Zheng W, et al. Prospective study of dietary carbohydrates, glycemic index, glycemic load, and incidence of type 2 diabetes mellitus in middle-aged Chinese women. Arch Intern Med. 2007;167(21):2310–6.CrossRefPubMed

17.

Hopping BN, Erber E, Grandinetti A, Verheus M, Kolonel LN, Maskarinec G. Dietary fiber, magnesium, and glycemic load alter risk of type 2 diabetes in a multiethnic cohort in Hawaii. J Nutr. 2010;140(1):68–74.PubMedCentralCrossRefPubMed

18.

Shikany JM, Judd SE, Letter AJ, Ard JD, Newby PK. Dietary contributors to glycemic load in the REasons for Geographic and Racial Differences in Stroke study. Nutrition. 2015;31(5):708–15.CrossRefPubMed

19.

Newby PK, Noel SE, Grant R, Judd S, Shikany JM, Ard J. Race and region are associated with nutrient intakes among black and white men in the United States. J Nutr;141(2):296–303

20.

Tonstad S, Stewart K, Oda K, Batech M, Herring RP, Fraser GE. Vegetarian diets and incidence of diabetes in the Adventist Health Study-2. Nutr Metab Cardiovasc Dis. 2013;23(4):292–9.PubMedCentralCrossRefPubMed

21.

Rhee JJ, Mattei J, Hughes MD, Hu FB, Willett WC. Dietary diabetes risk reduction score, race and ethnicity, and risk of type 2 diabetes in women. Diabetes Care. 2015;38(4):596–603.PubMed

22.

Chatterjee R, Colangelo LA, Yeh HC, Anderson CA, Daviglus ML, Liu K, et al. Potassium intake and risk of incident type 2 diabetes mellitus: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Diabetologia. 2012;55(5):1295–303.PubMedCentralCrossRefPubMed

23.

Panel on Dietary Reference Intakes for Electrolytes and Water. Chapter 5. Potassium dietary reference intakes for water, potassium, sodium, chloride, and sulfate.Washington DC: The National Academies Press. 2004. 186–268

24.

Chatterjee R, Yeh HC, Shafi T,et al. Serum and dietary potassium and risk of incident type 2 diabetes mellitus: The Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med. 170(19):1745–51.

25.

Chatterjee R, Yeh HC, Shafi T, Anderson C, Pankow JS, Miller ER, et al. Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) study. Am J Clin Nutr. 2011;93(5):1087–91.PubMedCentralCrossRefPubMed

26.

Ginde AA, Liu MC, Camargo Jr CA. Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004. Arch Intern Med. 2009;169(6):626–32.PubMedCentralCrossRefPubMed

27.

Nesby-O’Dell S, Scanlon KS, Cogswell ME, Gillespie C, Hollis BW, Looker AC, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey, 1988–1994. Am J Clin Nutr. 2002;76(1):187–92.PubMed

28.

Williams SK, Fiscella K, Winters P, Martins D, Ogedegbe G. Association of racial disparities in the prevalence of insulin resistance with racial disparities in vitamin D levels: National Health and Nutrition Examination Survey (2001–2006). Nutr Res. 2013;33(4):266–71.PubMedCentralCrossRefPubMed

29.

Robinson JG, Manson JE, Larson J, Liu S, Song Y, Howard BV, et al. Lack of association between 25(OH)D levels and incident type 2 diabetes in older women. Diabetes Care. 2011;34(3):628–34.PubMedCentralCrossRefPubMed

30.

Reis JP, Michos ED, Selvin E, Pankow JS, Lutsey PL. Race, vitamin D-binding protein gene polymorphisms, 25-hydroxyvitamin D, and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Am J Clin Nutr. 2015;101(6):1232–40.CrossRefPubMed

31.

Pittas AG, Dawson-Hughes B, Sheehan PR, Rosen CJ, Ware JH, Knowler WC, et al. Rationale and design of the vitamin D and type 2 diabetes (D2d) study: a diabetes prevention trial. Diabetes Care. 2014;37(12):3227–34.CrossRefPubMed

32.

Prevalence of self-reported physically active adults--United States, 2007. MMWR Morb Mortal Wkly Rep. 2008;57(48):1297–300.

33.

Ham SA, Ainsworth BE. Disparities in data on Healthy People 2010 physical activity objectives collected by accelerometry and self-report. Am J Public Health. 2010;100 Suppl 1:S263–8.PubMedCentralCrossRefPubMed

34.

Troiano RP, Berrigan D, Dodd KW, Masse LC, Tilert T, McDowell M. Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc. 2008;40(1):181–8.CrossRefPubMed

35.

DeLany JP, Dube JJ, Standley RA, Distefano G, Goodpaster BH, Stefanovic-Racic M, et al. Racial differences in peripheral insulin sensitivity and mitochondrial capacity in the absence of obesity. J Clin Endocrinol Metab. 2014;99(11):4307–14.PubMedCentralCrossRefPubMed

36.

Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2010;33(2):414–20.PubMedCentralCrossRefPubMed

37.

Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep. 2010;33(5):585–92.PubMedCentralPubMed

38.

Zizi F, Pandey A, Murrray-Bachmann R, Vincent M, McFarlane S, Ogedegbe G, et al. Race/ethnicity, sleep duration, and diabetes mellitus: analysis of the National Health Interview Survey. Am J Med. 2012;125(2):162–7.PubMedCentralCrossRefPubMed

39.••

Staiano AE, Harrington DM, Johannsen NM, Newton Jr RL, Sarzynski MA, Swift DL, et al. Uncovering physiological mechanisms for health disparities in type 2 diabetes. Ethn Dis. 2015;25(1):31–7. Review based on literature and expert opinion regarding important physiologic and genetic contributors to the racial disparity in diabetes risk.PubMed

40.

Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia. 1992;35(7):595–601.CrossRefPubMed

41.

Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia. 1993;36(1):62–7.CrossRefPubMed

42.

Hattersley AT, Tooke JE. The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet. 1999;353(9166):1789–92.CrossRefPubMed

43.

Ruiz-Narvaez EA, Palmer JR, Gerlovin H, Wise LA, Vimalananda VG, Rosenzweig JL, et al. Birth weight and risk of type 2 diabetes in the black women’s health study: does adult BMI play a mediating role? Diabetes Care. 2014;37(9):2572–8.PubMedCentralCrossRefPubMed

44.

Collins Jr JW, David RJ. Racial disparity in low birth weight and infant mortality. Clin Perinatol. 2009;36(1):63–73.CrossRefPubMed

45.

James-Todd T, Wise L, Boggs D, Rich-Edwards J, Rosenberg L, Palmer J. Preterm birth and subsequent risk of type 2 diabetes in black women. Epidemiology. 2014;25(6):805–10.PubMedCentralCrossRefPubMed

46.

Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115(5):1111–9.PubMedCentralCrossRefPubMed

47.

Catov JM, Bodnar LM, Ness RB, Barron SJ, Roberts JM. Inflammation and dyslipidemia related to risk of spontaneous preterm birth. Am J Epidemiol. 2007;166(11):1312–9.CrossRefPubMed

48.

Culhane JF, Goldenberg RL. Racial disparities in preterm birth. Semin Perinatol. 2011;35(4):234–9.CrossRefPubMed

49.

Selvin E, Halushka MK, Rawlings AM, Hoogeveen RC, Ballantyne CM, Coresh J, et al. sRAGE and risk of diabetes, cardiovascular disease, and death. Diabetes. 2013;62(6):2116–21.PubMedCentralCrossRefPubMed

50.

Maruthur NM, Li M, Halushka MK, Astor BC, Pankow JS, Boerwinkle E, et al. Genetics of plasma soluble receptor for advanced glycation end-products and cardiovascular outcomes in a community-based population: results from the Atherosclerosis Risk in Communities study. PLoS One. 2015;10(6), e0128452.PubMedCentralCrossRefPubMed

51.

Yeh HC, Punjabi NM, Wang NY, Pankow JS, Duncan BB, Brancati FL. Vital capacity as a predictor of incident type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care. 2005;28(6):1472–9.CrossRefPubMed

52.

Klein OL, Krishnan JA, Glick S, Smith LJ. Systematic review of the association between lung function and type 2 diabetes mellitus. Diabet Med. 27(9):977–87.

53.

Sentell TL, He G, Gregg EW, Schillinger D. Racial/ethnic variation in prevalence estimates for United States prediabetes under alternative 2010 American Diabetes Association criteria: 1988–2008. Ethn Dis. 2012;22(4):451–8.PubMed

54.••

Herman WH, Cohen RM. Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes. J Clin Endocrinol Metab. 2012;97(4):1067–72. Review of the advantages and disadvantages related to use of A1c testing in groups of different races/ethnicities.PubMedCentralCrossRefPubMed

55.

Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, Horton ES, et al. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care. 2007;30(10):2453–7.PubMedCentralCrossRefPubMed

56.

Viberti G, Lachin J, Holman R, Zinman B, Haffner S, Kravitz B, et al. A Diabetes Outcome Progression Trial (ADOPT): baseline characteristics of type 2 diabetic patients in North America and Europe. Diabet Med. 2006;23(12):1289–94.CrossRefPubMed

57.

Ziemer DC, Kolm P, Weintraub WS, Vaccarino V, Rhee MK, Twombly JG, et al. Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med. 2010;152(12):770–7.CrossRefPubMed

58.

Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362(9):800–11.PubMedCentralCrossRefPubMed

59.

Neeland IJ, Turer AT, Ayers CR, Powell-Wiley TM, Vega GL, Farzaneh-Far R, et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA. 2012;308(11):1150–9.PubMedCentralCrossRefPubMed

60.

Hanley AJ, Wagenknecht LE, Norris JM, Bryer-Ash M, Chen YI, Anderson AM, et al. Insulin resistance, beta cell dysfunction and visceral adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Family study. Diabetologia. 2009;52(10):2079–86.PubMedCentralCrossRefPubMed

61.

Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28(6):1039–49.CrossRefPubMed

62.

Despres JP, Couillard C, Gagnon J, Bergeron J, Leon AS, Rao DC, et al. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. Arterioscler Thromb Vasc Biol. 2000;20(8):1932–8.CrossRefPubMed

63.

Hill JO, Sidney S, Lewis CE, Tolan K, Scherzinger AL, Stamm ER. Racial differences in amounts of visceral adipose tissue in young adults: the CARDIA (Coronary Artery Risk Development in Young Adults) study. Am J Clin Nutr. 1999;69(3):381–7.PubMed

64.

Hoffman DJ, Wang Z, Gallagher D, Heymsfield SB. Comparison of visceral adipose tissue mass in adult African Americans and whites. Obes Res. 2005;13(1):66–74.CrossRefPubMed

65.

Bray GA, Jablonski KA, Fujimoto WY, Barrett-Connor E, Haffner S, Hanson RL, et al. Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr. 2008;87(5):1212–8.PubMedCentralPubMed

66.

Conway JM, Yanovski SZ, Avila NA, Hubbard VS. Visceral adipose tissue differences in black and white women. Am J Clin Nutr. 1995;61(4):765–71.PubMed

67.

Kanaley JA, Giannopoulou I, Tillapaugh-Fay G, Nappi JS, Ploutz-Snyder LL. Racial differences in subcutaneous and visceral fat distribution in postmenopausal black and white women. Metabolism. 2003;52(2):186–91.CrossRefPubMed

68.

Katzmarzyk PT, Bray GA, Greenway FL, Johnson WD, Newton Jr RL, Ravussin E, et al. Racial differences in abdominal depot-specific adiposity in white and African American adults. Am J Clin Nutr. 2010;91(1):7–15.CrossRefPubMed

69.

Toledo-Corral CM, Alderete TL, Hu HH, Nayak K, Esplana S, Liu T, et al. Ectopic fat deposition in prediabetic overweight and obese minority adolescents. J Clin Endocrinol Metab. 2013;98(3):1115–21.PubMedCentralCrossRefPubMed

70.

Alderete TL, Toledo-Corral CM, Desai P, Weigensberg MJ, Goran MI. Liver fat has a stronger association with risk factors for type 2 diabetes in African-American compared with Hispanic adolescents. J Clin Endocrinol Metab. 2013;98(9):3748–54.PubMedCentralCrossRefPubMed

71.

McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med. 2010;363(24):2339–50.CrossRefPubMed

72.

Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010;42(7):579–89.PubMedCentralCrossRefPubMed

73.

Kooner JS, Saleheen D, Sim X, Sehmi J, Zhang W, Frossard P, et al. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet. 2011;43(10):984–9.PubMedCentralCrossRefPubMed

74.

Cho YS, Chen CH, Hu C, Long J, Ong RT, Sim X, et al. Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in East Asians. Nat Genet. 2012;44(1):67–72.CrossRef

75.

Palmer ND, McDonough CW, Hicks PJ, Roh BH, Wing MR, An SS, et al. A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One. 2012;7(1), e29202.PubMedCentralCrossRefPubMed

76.

Morris AP, Voight BF, Teslovich TM, Ferreira T, Segre AV, Steinthorsdottir V, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44(9):981–90.PubMedCentralCrossRefPubMed

77.

Replication DIG, Meta-analysis C. Asian Genetic Epidemiology Network Type 2 Diabetes C, South Asian Type 2 Diabetes C, Mexican American Type 2 Diabetes C, Type 2 Diabetes Genetic Exploration by Next-generation sequencing in multi-Ethnic Samples C, et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet. 2014;46(3):234–44.CrossRef

78.

Ng MC, Shriner D, Chen BH, Li J, Chen WM, Guo X, et al. Meta-analysis of genome-wide association studies in African Americans provides insights into the genetic architecture of type 2 diabetes. PLoS Genet. 2014;10(8), e1004517.PubMedCentralCrossRefPubMed

79.

Meigs JB, Grant RW, Piccolo R, Lopez L, Florez JC, Porneala B, et al. Association of African genetic ancestry with fasting glucose and HbA1c levels in non-diabetic individuals: the Boston Area Community Health (BACH) prediabetes study. Diabetologia. 2014;57(9):1850–8.CrossRefPubMed

80.

Maruthur NM, Kao WH, Clark JM, Brancati FL, Cheng CY, Pankow JS, et al. Does genetic ancestry explain higher values of glycated hemoglobin in African Americans? Diabetes. 2011;60(9):2434–8.PubMedCentralCrossRefPubMed

81.•

Maruthur NM. The growing prevalence of type 2 diabetes: increased incidence or improved survival? Curr Diab Rep. 2013;13(6):786–94. Review of risk factors impacting diabetes and diabetes risk world-wide.CrossRefPubMed

Title: Novel Risk Factors for Type 2 Diabetes in African-Americans
Authors: Ranee Chatterjee
Nisa M. Maruthur
David Edelman
Publication date: 01-12-2015
Publisher: Springer US
Published in: Current Diabetes Reports / Issue 12/2015
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI: https://doi.org/10.1007/s11892-015-0675-5

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2015

Therapies on the Horizon for Diabetic Kidney Disease

Challenges and Opportunities in the Management of Cardiovascular Risk Factors in Youth With Type 1 Diabetes: Lifestyle and Beyond

Hypoxia and Dark Adaptation in Diabetic Retinopathy: Interactions, Consequences, and Therapy

Undiagnosed MODY: Time for Action

Exercise as Therapy for Diabetic and Prediabetic Neuropathy

Retinal Failure in Diabetes: a Feature of Retinal Sensory Neuropathy

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials